NanoCytomics

Evanston, United States Founded: 2011 • Age: 15 yrs
Imaging-based diagnostic devices for cancer are developed.

About NanoCytomics

NanoCytomics is a Technology company based in Evanston (United States) founded in 2011. Imaging-based diagnostic devices for cancer are developed. It operates in the Technology and Healthcare sectors. NanoCytomics offers products and services including PWS Platform, Nanocytology, and Field Effect Technology. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is NanoCytomics LLC. Its competitors include Scholar Rock, Ionpath and Fluxion Biosciences; 3 of its 3 listed competitors have raised funding.

Company details

NanoCytomics was founded in 2011 in Evanston, United States, within the biotechnology sector. Diagnostic devices utilizing imaging technologies are developed to detect cancer through nanoscale analysis of cellular structures. An exclusive license from Northwestern University is maintained for patents on partial wave spectroscopic microscopy, which enables optical sensing of cell functions and abnormalities. Operations center on advancing biophotonics for early cancer identification.

  • Headquarters Evanston, United States
  • Sectors
    Technology
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website nano-cytomics.com
  • Social LinkedIn
  • Legal Name Nanocytomics Llc
Operational Areas
Key Metrics
  • Latest Funding Round
    $3.47M (USD), Grant

    Sep 2012

  • Investors
    HHS

    & 1 more

Products & Services of NanoCytomics

NanoCytomics offers a comprehensive portfolio of products and services, including PWS Platform, Nanocytology, and Field Effect Technology.

PWS Platform
Diagnostic Tool

Provides non-invasive cancer risk assessment for early detection

Nanocytology
Testing Technology

Enables accurate, low-cost analysis of cancer risks in patients

Field Effect Technology
Analytical Platform

Offers fingerprint-based risk discovery for cancer screening

Funding Insights of NanoCytomics

  • Total Rounds 3
  • Last Round Grant β€” $3.47M
  • First Round $149,970

    (May 2012)

  • Investors Count 2

All 3 funding rounds of NanoCytomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2012$3.47MGrant––
Jul 2012$149,970Grant––
May 2012$149,970Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in NanoCytomics

NanoCytomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Premium access

Investor details for NanoCytomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of NanoCytomics

3 dated milestones of NanoCytomics across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded NanoCytomics is founded.
  2. Funding First funding round of $150K.
  3. Funding Latest funding round, Grant, of $3.5M.

Competitors of NanoCytomics

NanoCytomics has 3 listed competitors in our database, 3 of them funded. They include Scholar Rock, Ionpath and Fluxion Biosciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
scholarrock.com2012Cambridge, United States$103.3M150
Antibody-based drugs for primary myopathies are developed and targeted.
ionpath.com2014Menlo Park, United States$18M37
Multiplexed ion beam imaging platform for tissue biopsies is developed.
fluxionbio.com2005San Francisco, United States$20.85M
Microfluidics-based tools for cellular analysis are provided.
Premium access

Detailed competitors of NanoCytomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Nanotechnology

3 companies that operate in the same segment as NanoCytomics (Nanotechnology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of technologies for analysis of genetic variation and function
1993San Diego, California, United StatesUSD 28 MUSD 34.92 M9,630
RNA interference-based therapeutics are developed for multiple disorders.
2002Cambridge, Massachusetts, United StatesUSD 17 MUSD 3.71 B2,230
Aerogel-based thermal insulation solutions are provided for energy conservation.
2001United StatesUSD 198.35 MUSD 271.1 M554
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about NanoCytomics

NanoCytomics was founded in 2011 and raised its 1st funding round 1 year after it was founded.

NanoCytomics is headquartered in Evanston, United States. It is registered at Evanston, Illinois, United States.

NanoCytomics was founded in 2011 in Evanston, United States, within the biotechnology sector. Diagnostic devices utilizing imaging technologies are developed to detect cancer through nanoscale analysis of cellular structures. An exclusive license from Northwestern University is maintained for patents on partial wave spectroscopic microscopy, which enables optical sensing of cell functions and abnormalities. Operations center on advancing biophotonics for early cancer identification.

NanoCytomics's top competitors include Scholar Rock, Ionpath and Fluxion Biosciences.

NanoCytomics offers PWS Platform, Nanocytology, and Field Effect Technology.

NanoCytomics has 2 investors. Key investors include HHS, and National Science Foundation.

NanoCytomics operates through Nanocytomics Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available